Clinical Trial Update: Evaluation of Prevalence and Risk Factors of Persistent COVID-19 in Immunocompromised Patients

View source ↗

Summary

This clinical trial update evaluates the prevalence and risk factors of persistent COVID-19 in immunocompromised patients, focusing on those with B-cell maligna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies
• Persistent COVID-19

Snippet

Sponsor: Maddalena Giannella | Conditions: Persistent COVID-19, B Cell Malignancies | Status: ACTIVE_NOT_RECRUITING